About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [307 citations: 101–200 of 291 articles]

Articles published in Prostate Cancer have been cited 307 times. The following is a list of the 291 articles that have cited the articles published in Prostate Cancer.

  • Angela Calastretti, Giuliana Gatti, Carolina Quaresmini, and Annamaria Bevilacqua, “Down-modulation of Bcl-2 sensitizes PTEN-mutated prostate cancer cells to starvation and taxanes,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • A. Brett Hauber, Jorge Arellano, Yi Qian, Juan Marcos González, Joshua D. Posner, Ateesha F. Mohamed, Francesca Gatta, Bertrand Tombal, and Jean-Jacques Body, “Patient preferences for treatments to delay bone metastases,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Kenneth C. Valkenburg, Xiuping Yu, Angelo M. De Marzo, Tyler J. Spiering, Robert J. Matusik, and Bart O. Williams, “Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Petra Hudler, Nina Kocevar, and Radovan Komel, “Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics,” The Scientific World Journal, vol. 2014, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Nihar K. Patel, Antoine Finianos, Kristen D. Whitaker, and Jeanny B. Aragon-Ching, “Advanced prostate cancer - patient survival and potential impact of enzalutamide and other emerging therapies,” Therapeutics and Clinical Risk Management, vol. 10, pp. 651–664, 2014. View at Publisher · View at Google Scholar
  • Ruiqin Wu, Yaxiong Cui, Xiaoyan Yuan, Haitao Yuan, Yimei Wang, Jun He, Jun Zhao, and Shuangqing Peng, “SUMO-specific protease 1 modulates cadmium-augmented transcriptional activity of androgen receptor (AR) by reversing AR SUMOylation,” Toxicology Letters, vol. 229, no. 2, pp. 405–413, 2014. View at Publisher · View at Google Scholar
  • Anna Supernat, Sylwia Łapińska-Szumczyk, Hanna Majewska, Jacek Gulczyński, Wojciech Biernat, Dariusz Wydra, and Anna J. Żaczek, “Tumor Heterogeneity at Protein Level as an Independent Prognostic Factor in Endometrial Cancer,” Translational Oncology, 2014. View at Publisher · View at Google Scholar
  • Erik H. Knelson, Jasmine C. Nee, and Gerard C. Blobe, “Heparan sulfate signaling in cancer,” Trends in Biochemical Sciences, 2014. View at Publisher · View at Google Scholar
  • Juliana Inês Santos, Ana Luísa Teixeira, Francisca Dias, Mónica Gomes, Augusto Nogueira, Joana Assis, and Rui Medeiros, “Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • Xiao-Feng He, Zhi-Zhong Liu, Jian-Jun Xie, Wei Wang, Ya-Ping Du, Yu Chen, and Wu Wei, “Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • Jacques Gilloteaux, James M. Jamison, Deborah Neal, and Jack L. Summers, “Synergistic Antitumor Cytotoxic Actions of Ascorbate and Menadione on Human Prostate (DU145) Cancer Cells In Vitro: Nucleus and Other Injuries Preceding Cell Death by Autoschizis,” Ultrastructural Pathology, vol. 38, no. 2, pp. 116–140, 2014. View at Publisher · View at Google Scholar
  • Jian Gang Pan, Chun Jiang, Runqi Luo, and Xing Zhou, “Association of Metabolic Syndrome and Benign Prostatic Hyperplasia in Chinese Patients of Different Age Decades,” Urologia Internationalis, vol. 93, no. 1, pp. 10–16, 2014. View at Publisher · View at Google Scholar
  • Monique J. Roobol, “International Perspectives on Screening,” Urologic Clinics of North America, vol. 41, no. 2, pp. 237–247, 2014. View at Publisher · View at Google Scholar
  • Akshay Sood, Wooju Jeong, James O. Peabody, Ashok K. Hemal, and Mani Menon, “Robot-Assisted Radical Prostatectomy,” Urologic Clinics of North America, 2014. View at Publisher · View at Google Scholar
  • Huan Ding, Ying Sun, Yu Hou, and Li Li, “Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy—Resistant prostate cancer cell line, PC3,” Urologic Oncology: Seminars and Original Investigations, 2014. View at Publisher · View at Google Scholar
  • Brandon A. Mahal, David R. Ziehr, Ayal A. Aizer, Andrew S. Hyatt, Jesse D. Sammon, Marianne Schmid, Toni K. Choueiri, Jim C. Hu, Christopher J. Sweeney, Clair J. Beard, Anthony V. D׳Amico, Neil E. Martin, Christopher Lathan, Simon P. Kim, Quoc-Dien Trinh, and Paul L. Nguyen, “Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer,” Urologic Oncology: Seminars and Original Investigations, 2014. View at Publisher · View at Google Scholar
  • Dae-Seon Yoo, Seung Hyo Woo, Seok Cho, Seok Ho Kang, Sang Jin Kim, Sung Yul Park, Sang Hyub Lee, Seung Hyun Jeon, and Jinsung Park, “Practice Patterns of Urologists in Managing Korean Men Aged 40 Years or Younger With High Serum Prostate-specific Antigen Levels,” Urology, 2014. View at Publisher · View at Google Scholar
  • Brandon A. Mahal, Michael P. O'Leary, and Paul L. Nguyen, “Hydrogel Spacing for Radiotherapy of Prostate Cancer: A Review of the Literature,” Urology Practice, 2014. View at Publisher · View at Google Scholar
  • Jakub Dobruch, Sebastian Piotrowicz, Michal Skrzypczyk, Tomasz Golabek, Piotr Chlosta, and Andrzej Borowka, “Clinical value of extended pelvic lymph node dissection in patients subjected to radical prostatectomy,” Videosurgery and Other Miniinvasive Techniques, vol. 9, no. 1, pp. 64–70, 2014. View at Publisher · View at Google Scholar
  • Marianne Schmid, Qd Quoc-Dien Trinh, Markus Graefen, Margit Fisch, Felix K. Chun, and Jens Hansen, “The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: Which markers matter and how should they be used?,” World Journal of Urology, vol. 32, no. 4, pp. 871–880, 2014. View at Publisher · View at Google Scholar
  • Adam D. Toll, and Syed Z. Ali, “Urinary Cytomorphology and Clinical Correlates of Prostatic Small Cell Neuroendocrine Carcinoma,” Acta Cytologica, vol. 57, no. 5, pp. 495–500, 2013. View at Publisher · View at Google Scholar
  • Anna Pettersson, Ingela Turesson, Christina Persson, and Birgitta Johansson, “Assessing patients’ perceived bother from the gastrointestinal side effects of radiotherapy for localized prostate cancer: Initial questionnaire development and validation,” Acta Oncologica, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Kevin Krughoff, Khadijah Eid, Jason Phillips, Diliana Stoimenova, Daniel Smith, Colin O’Donnell, E. David Crawford, and Al Barqawi, “The Accuracy of Prostate Cancer Localization Diagnosed on Transrectal Ultrasound-Guided Biopsy Compared to 3-Dimensional Transperineal Approach,” Advances in Urology, vol. 2013, pp. 1–5, 2013. View at Publisher · View at Google Scholar
  • H. S. Park, J. D. Schoenfeld, R. B. Mailhot, M. Shive, R. I. Hartman, R. Ogembo, and L. A. Mucci, “Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis,” Annals of Oncology, 2013. View at Publisher · View at Google Scholar
  • Tanya I. Stoyanova, and Andrew S. Goldstein, “Identification, characterization and targeting of Docetaxel-resistant prostate cancer cells,” Asian Journal Of Andrology, vol. 15, no. 1, pp. 83–84, 2013. View at Publisher · View at Google Scholar
  • Yun-Fei Li, Shao-Feng Zhang, Tao-Tao Zhang, Lei Li, Wei Gan, Hong-Tao Jia, Sheng Xie, Hui-Hua Ji, and Da-Lin He, “Intermittent tri-weekly docetaxel plus bicalutamide in patients with castration-resistant prostate cancer: a single-arm prospective study using a historical control for comparison,” Asian Journal of Andrology, 2013. View at Publisher · View at Google Scholar
  • Dong Il Kang, Jae Il Chung, Hong Koo Ha, Kweonsik Min, Jangho Yoon, Wansuk Kim, Won Ik Seo, Pil moon Kang, Soo Jin Jung, and Isaac Yi Kim, “Korean Prostate Cancer Patients Have Worse Disease Characteristics than their American Counterparts,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 11, pp. 6913–6917, 2013. View at Publisher · View at Google Scholar
  • Mathis Grossmann, Ada S. Cheung, and Jeffrey D. Zajac, “Androgens and prostate cancer; pathogenesis and deprivation therapy,” Best Practice & Research Clinical Endocrinology & Metabolism, 2013. View at Publisher · View at Google Scholar
  • Jean-Joseph Hoang, Silvère Baron, David H. Volle, Jean-Marc A. Lobaccaro, and Amalia Trousson, “Lipids, LXRs and prostate cancer: Are HDACs a new link?,” Biochemical Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Hai-Dong Yao, Qiong Wu, Zi-Wei Zhang, Shu Li, Xiao-Long Wang, Xin-Gen Lei, and Shi-Wen Xu, “Selenoprotein W serves as an antioxidant in chicken myoblasts,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1830, no. 4, pp. 3112–3120, 2013. View at Publisher · View at Google Scholar
  • Sophie E McGrath, Agnieszka Michael, Richard Morgan, and Hardev Pandha, “EN2: a novel prostate cancer biomarker,” Biomarkers in Medicine, vol. 7, no. 6, pp. 893–901, 2013. View at Publisher · View at Google Scholar
  • Awatef Ben Jemaa, Yosra Bouraoui, Sataa Sallami, Yassine Nouira, and Ridha Oueslati, “A Comparison of the Biological Features of Prostate Cancer with (PSA+, PSMA+) Profile according to RKIP,” BioMed Research International, vol. 2013, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • M. L. Verschoor, R. Ungard, A. Harbottle, J. P. Jakupciak, R. L. Parr, and G. Singh, “Mitochondria and Cancer: Past, Present, and Future,” Biomed Research International, 2013. View at Publisher · View at Google Scholar
  • Martin Andreas Røder, Klaus Brasso, Ib Jarle Christensen, Jørgen Johansen, Niels Christian Langkilde, Helle Hvarness, Steen Carlsson, Henrik Jakobsen, Michael Borre, and Peter Iversen, “Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study,” BJU International, 2013. View at Publisher · View at Google Scholar
  • Bao-Li Chang, Lucinda Hughes, David Y.T. Chen, Laura Gross, Karen Ruth, and Veda N. Giri, “Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer,” BJU International, 2013. View at Publisher · View at Google Scholar
  • H. Ballentine Carter, “American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale,” BJU International, vol. 112, no. 5, pp. 543–547, 2013. View at Publisher · View at Google Scholar
  • Christian Barré, Matthieu Thoulouzan, Geneviève Aillet, and Jean-Michel Nguyen, “Assessing the extirpative quality of a radical prostatectomy technique: categorisation and mapping of technical errors,” BJU International, 2013. View at Publisher · View at Google Scholar
  • Philip A. Fontenot, and Ahmed M. Mansour, “Reporting positive surgical margins after radical prostatectomy: time for standardization,” BJU International, 2013. View at Publisher · View at Google Scholar
  • Elizabeth A. Tindall, M. S. Riana Bornman, Smit van Zyl, Alpheus M. Segone, L. Richard Monare, Philip A. Venter, and Vanessa M. Hayes, “Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa,” Bmc Urology, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Joshua B. Stevens, Steven D. Horne, Batoul Y. Abdallah, Christine J. Ye, and Henry H. Heng, “Chromosomal instability and transcriptome dynamics in cancer,” Cancer and Metastasis Reviews, 2013. View at Publisher · View at Google Scholar
  • Archana Mukhopadhyay, Kayann Tabanor, Rathnam Chaguturu, and Jane V Aldrich, “Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment,” Cancer Biology & Therapy, vol. 14, no. 10, 2013. View at Publisher · View at Google Scholar
  • Dana E. Rathkopf, Joel Picus, Arif Hussain, Susan Ellard, Kim Nguyen Chi, Thomas Nydam, Erin Allen-Freda, Kaushal Kishor Mishra, Maria Grazia Porro, Howard I. Scher, and George Wilding, “A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer,” Cancer Chemotherapy and Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Julie Ruterbusch, Cathryn H. Bock, Steve Lenk, Mehsati Herawi, Richard Everson, Craig N. Giroux, Ann G. Schwartz, Aliccia Bollig-Fischer, Isaac J. Powell, Greg Dyson, and Susan Land, “Genes Associated with Prostate Cancer Are Differentially Expressed in African American and European American Men,” Cancer Epidemiology Biomarkers & Prevention, vol. 22, no. 5, pp. 891–897, 2013. View at Publisher · View at Google Scholar
  • Michael R. Burgio, John P. A. Ioannidis, Brett M. Kaminski, Eric DeRycke, Scott Rogers, Muin J. Khoury, and Daniela Seminara, “Collaborative Cancer Epidemiology in the 21st Century: The Model of Cancer Consortia,” Cancer Epidemiology Biomarkers & Prevention, vol. 22, no. 12, pp. 2148–2160, 2013. View at Publisher · View at Google Scholar
  • Thippeswamy Gulappa, Ramadevi Subramani Reddy, Suman Suman, Alice M. Nyakeriga, and Chendil Damodaran, “Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells,” Cancer Letters, 2013. View at Publisher · View at Google Scholar
  • Brigitte N. Gomperts, Tonya C. Walser, Avrum Spira, and Steven M. Dubinett, “Enriching the Molecular Definition of the Airway "Field of Cancerization:" Establishing New Paradigms for the Patient at Risk for Lung Cancer,” Cancer Prevention Research, vol. 6, no. 1, pp. 4–7, 2013. View at Publisher · View at Google Scholar
  • Nicholas G. Zaorsky, Matthew T. Studenski, Adam P. Dicker, Leonard Gomella, and Robert B. Den, “Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care?,” Cancer Treatment Reviews, vol. 39, no. 3, pp. 212–218, 2013. View at Publisher · View at Google Scholar
  • S. Supiot, G. Créhange, I. Latorzeff, P. Pommier, A. Paumier, E. Rio, G. Delaroche, S. Guérif, C. Catton, J. Martin, and A. Lisbona, “Hypofractionnement à visée curative dans le cancer de la prostate,” Cancer/Radiothérapie, 2013. View at Publisher · View at Google Scholar
  • A. R. Verone, K. Duncan, A. Godoy, N. Yadav, A. Bakin, S. Koochekpour, J.-P. Jin, and H. V. Heemers, “Androgen-responsive Serum Response Factor target genes regulate prostate cancer cell migration,” Carcinogenesis, 2013. View at Publisher · View at Google Scholar
  • S Wang, J Huang, H Lyu, C-K Lee, J Tan, J Wang, and B Liu, “Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells,” Cell Death and Disease, vol. 4, no. 3, pp. e556, 2013. View at Publisher · View at Google Scholar
  • Zheng-Yuan Su, Tin Oo Khor, Limin Shu, Jong Hun Lee, Constance Lay-Lay Saw, Tien-Yuan Wu, Ying Huang, Nanjoo Suh, Chung S. Yang, Allan H. Conney, Qing Wu, and Ah-Ng Tony Kong, “ Epigenetic Reactivation of Nrf2 in Murine Prostate Cancer TRAMP C1 Cells by Natural Phytochemicals Z-Ligustilide and Radix Angelica Sinensis via Promoter CpG Demethylation ,” Chemical Research in Toxicology, vol. 26, no. 3, pp. 477–485, 2013. View at Publisher · View at Google Scholar
  • Kenneth C. Valkenburg, Matthew R. Steensma, Bart O. Williams, and Zhendong Zhong, “Skeletal metastasis: Treatments, mouse models, and the Wnt signaling,” Chinese Journal of Cancer, vol. 32, no. 7, pp. 380–396, 2013. View at Publisher · View at Google Scholar
  • S. Dijkstra, P.F.A. Mulders, and J.A. Schalken, “Clinical Use of Novel Urine and Blood Based Prostate Cancer Biomarkers: a review,” Clinical Biochemistry, 2013. View at Publisher · View at Google Scholar
  • Sucharitha Balasubramaniam, Clay E. S. Comstock, Adam Ertel, Kwang Won Jeong, Michael R. Stallcup, Sankar Addya, Peter A. McCue, William F. Ostrander, Michael A. Augello, and Karen E. Knudsen, “Aberrant BAF57 Signaling Facilitates Prometastatic Phenotypes,” Clinical Cancer Research, vol. 19, no. 10, pp. 2657–2667, 2013. View at Publisher · View at Google Scholar
  • Patrick Berkovic, Gert De Meerleer, Louke Delrue, Bieke Lambert, Valérie Fonteyne, Nicolaas Lumen, Karel Decaestecker, Geert Villeirs, Philippe Vuye, and Piet Ost, “Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy,” Clinical Genitourinary Cancer, vol. 11, no. 1, pp. 27–32, 2013. View at Publisher · View at Google Scholar
  • Matthew C. Ward, Rahul D. Tendulkar, Jay P. Ciezki, and Eric A. Klein, “Future Directions From Past Experience: A Century of Prostate Radiotherapy,” Clinical Genitourinary Cancer, 2013. View at Publisher · View at Google Scholar
  • S. Sridharan, A. Dal Pra, C. Catton, R.G. Bristow, and P. Warde, “Locally Advanced Prostate Cancer: Current Controversies and Optimisation Opportunities,” Clinical Oncology, 2013. View at Publisher · View at Google Scholar
  • L. Dickinson, H.U. Ahmed, A. Kirkham, C. Allen, A. Freeman, J. Barber, R. Hindley, T. Leslie, C. Ogden, R. Persad, M.H. Winkler, and M. Emberton, “A Multi-Centre Prospective Development Study Evaluating Focal Therapy using High Intensity Focused Ultrasound for Localised Prostate Cancer: The INDEX Study,” Contemporary Clinical Trials, 2013. View at Publisher · View at Google Scholar
  • Jeffry L. Dean, “The Role of Tumor Suppressor Dysregulation in Prostate Cancer Progression,” Current Drug Targets, vol. 14, no. 4, pp. 460–471, 2013. View at Publisher · View at Google Scholar
  • F. El-Gehani, K. Joseph, A. Dechaphunkul, M. Kamal, D. Pertschy, P. Venner, S. Ghosh, and S. North, “Genitourinary small-cell carcinoma: a single-institution experience,” Current Oncology, vol. 20, no. 5, pp. 258–264, 2013. View at Publisher · View at Google Scholar
  • Sausan Abouharb, and Paul G. Corn, “Optimal Therapy Sequencing in Metastatic Castration-Resistant Prostate Cancer,” Current Oncology Reports, vol. 15, no. 3, pp. 217–223, 2013. View at Publisher · View at Google Scholar
  • Sonia Liberati, Giorgio Santoni, Maria Beatrice Morelli, Massimo Nabissi, and Matteo Santoni, “Oncogenic and Anti-Oncogenic Effects of Transient Receptor Potential Channels,” Current Topics In Medicinal Chemistry, vol. 13, no. 3, pp. 344–366, 2013. View at Publisher · View at Google Scholar
  • Phillip J. Gray, and Jason A. Efstathiou, “Proton Beam Radiation Therapy for Prostate Cancer—Is the Hype (and the Cost) Justified?,” Current Urology Reports, 2013. View at Publisher · View at Google Scholar
  • Gonzalo Rodríguez-Berriguete, Beatriz Sánchez-Espiridión, José R. Cansino, Gabriel Olmedilla, Pilar Martínez-Onsurbe, Manuel Sánchez-Chapado, Ricardo Paniagua, Benito Fraile, and Mar Royuela, “Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer,” Cytokine, 2013. View at Publisher · View at Google Scholar
  • J. Hübner, “Update 2013 Komplementäre Onkologie,” Der Onkologe, 2013. View at Publisher · View at Google Scholar
  • B.J. Schmitz-Dräger, G. Lümmen, E. Bismarck, and C. Fischer, “Metabolisches Syndrom und Prostatakarzinom,” Der Urologe, 2013. View at Publisher · View at Google Scholar
  • Yan-bing Ding, Bin Deng, You-sheng Huang, Wei-ming Xiao, Jian Wu, Yan-qing Zhang, Yuan-zhi Wang, Da-cheng Wu, Guo-tao Lu, and Ke-yan Wu, “A High Level of Integrin α6 Expression in Human Intrahepatic Cholangiocarcinoma Cells Is Associated with a Migratory and Invasive Phenotype,” Digestive Diseases and Sciences, vol. 58, no. 6, pp. 1627–1635, 2013. View at Publisher · View at Google Scholar
  • Elizabeth M. Hechenbleikner, Jill C. Buckley, and Elizabeth C. Wick, “Acquired Rectourethral Fistulas in Adults,” Diseases of the Colon & Rectum, vol. 56, no. 3, pp. 374–383, 2013. View at Publisher · View at Google Scholar
  • Sébastien Fortin, Kevin Brasseur, Nathalie Morin, Éric Asselin, and Gervais Bérubé, “New platinum(II) complexes conjugate at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: Design, synthesis, structure-activity relationships and biological evaluation,” European Journal of Medicinal Chemistry, 2013. View at Publisher · View at Google Scholar
  • Amit Bahl, “Metastatic castration-resistant prostate cancer. Part 1: the challenges of the disease and its treatment,” European Journal of Oncology Nursing, vol. 17, pp. S1–S6, 2013. View at Publisher · View at Google Scholar
  • Andrew Close, Clare Robertson, Stephen Rushton, Mark Shirley, Luke Vale, Craig Ramsay, and Robert Pickard, “Comparative Cost-effectiveness of Robot-assisted and Standard Laparoscopic Prostatectomy as Alternatives to Open Radical Prostatectomy for Treatment of Men with Localised Prostate Cancer: A Health Technology Assessment from the Perspective of the UK National Health Service,” European Urology, 2013. View at Publisher · View at Google Scholar
  • Axel Heidenreich, Patrick J. Bastian, Joaquim Bellmunt, Michel Bolla, Steven Joniau, Theodor van der Kwast, Malcolm Mason, Vsevolod Matveev, Thomas Wiegel, F. Zattoni, and Nicolas Mottet, “EAU Guidelines on Prostate Cancer, Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2014,” European Urology, 2013. View at Publisher · View at Google Scholar
  • Zhijun Wang, Jeffery Fan, Mandy Liu, Steven Yeung, Andy Chang, Moses SS Chow, Doreen Pon, and Ying Huang, “Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application,” Expert Opinion on Investigational Drugs, pp. 1–14, 2013. View at Publisher · View at Google Scholar
  • Rahul R Deshmukh, Sara M Schmitt, Clara Hwang, and Qing Ping Dou, “Chemotherapeutic inhibitors in the treatment of prostate cancer,” Expert Opinion on Pharmacotherapy, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  • Guillaume Ploussard, and Pierre Mongiat-Artus, “Triptorelin in the management of prostate cancer,” Future Oncology, vol. 9, no. 1, pp. 93–102, 2013. View at Publisher · View at Google Scholar
  • Michael Blaise Cook, Zhaoming Wang, Edward D. Yeboah, Yao Tettey, Richard B. Biritwum, Andrew A. Adjei, Evelyn Tay, Ann Truelove, Shelley Niwa, Charles C. Chung, Annand P. Chokkalingam, Lisa W. Chu, Meredith Yeager, Amy Hutchinson, Kai Yu, Kristin A. Rand, Christopher A. Haiman, Robert N. Hoover, Ann W. Hsing, and Stephen J. Chanock, “A genome-wide association study of prostate cancer in West African men,” Human Genetics, 2013. View at Publisher · View at Google Scholar
  • Julie K. Bassett, Gianluca Severi, Allison M. Hodge, Robert J. MacInnis, Robert A. Gibson, John L. Hopper, Dallas R. English, and Graham G. Giles, “Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk,” International Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • Zaki Shaikhibrahim, Roopika Menon, Martin Braun, Anne Offermann, Angela Queisser, Diana Boehm, Wenzel Vogel, Kerstin Rüenauver, Christian Ruiz, Tobias Zellweger, Maria Svensson, Ove Andren, Glen Kristiansen, Nicolas Wernert, Lukas Bubendorf, Jutta Kirfel, Saskia Biskup, and Sven Perner, “ MED15 , encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer ,” International Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • Priya Bhosale, Aparna Balachandran, Raghu Vikram, Chitra Viswanathan, Homer Macapinlac, Eric Rohren, and Ramanujan Prativadi, “What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies?,” International Journal of Molecular Imaging, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Sakthivel Muniyan, Nagendra Chaturvedi, Jennifer Dwyer, Chad LaGrange, William Chaney, and Ming-Fong Lin, “Human Prostatic Acid Phosphatase: Structure, Function and Regulation,” International Journal of Molecular Sciences, vol. 14, no. 5, pp. 10438–10464, 2013. View at Publisher · View at Google Scholar
  • Colin Cooper, Jaume Reventos, Jeremy Clark, Melania Montes, Eva Colas, Jacques Planas, Andreas Doll, Marta Garcia, Tamara Sequeiros, Marta Llaurado, Ines de Torres, Marina Rigau, Juan Morote, and Mireia Olivan, “The Present and Future of Prostate Cancer Urine Biomarkers,” International Journal Of Molecular Sciences, vol. 14, no. 6, pp. 12620–12649, 2013. View at Publisher · View at Google Scholar
  • James Farrell, Gyorgy Petrovics, David G. McLeod, and Shiv Srivastava, “Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men,” International Journal of Molecular Sciences, vol. 14, no. 8, pp. 15510–15531, 2013. View at Publisher · View at Google Scholar
  • Godwin O. Ifere, Renee Desmond, Wendy Demark-Wahnefried, and Tim R. Nagy, “Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis,” International Journal of Oncology, vol. 43, no. 4, pp. 1002–1010, 2013. View at Publisher · View at Google Scholar
  • D. Le Broc-Ryckewaert, R. Carpentier, E. Lipka, S. Daher, C. Vaccher, D. Betbeder, and C. Furman, “Development of innovative paclitaxel-loaded small PLGA nanoparticles: Study of their antiproliferative activity and their molecular interactions on prostatic cancer cells,” International Journal of Pharmaceutics, 2013. View at Publisher · View at Google Scholar
  • Takahiro Kimura, Masahito Kido, Kenta Miki, Toshihiro Yamamoto, Hiroshi Sasaki, Hidetoshi Kuruma, Norihiro Hayashi, Hiroyuki Takahashi, Manabu Aoki, and Shin Egawa, “Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients,” International Journal of Urology, 2013. View at Publisher · View at Google Scholar
  • Anup Vora, Tim Large, Jenny Aronica, Sherod Haynes, Andrew Harbin, Daniel Marchalik, Hanaa Nissim, John Lynch, Gaurav Bandi, Kevin McGeagh, Keith Kowalczyk, Reza Ghasemian, Krishnan Venkatesan, Mohan Verghese, and Jonathan Hwang, “Predictors of Gleason score upgrading in a large African-American population,” International Urology and Nephrology, vol. 45, no. 5, pp. 1257–1262, 2013. View at Publisher · View at Google Scholar
  • S. Voros, A. Moreau-Gaudry, B. Tamadazte, G. Custillon, R. Heus, M.-P. Montmasson, F. Giroud, O. Gaiffe, C. Pieralli, G. Fiard, J.-A. Long, J.-L. Descotes, C. Vidal, A. Nguyen-Dinh, and P. Cinquin, “Devices and systems targeted towards augmented robotic radical prostatectomy,” Irbm, vol. 34, no. 2, pp. 139–146, 2013. View at Publisher · View at Google Scholar
  • Cheng Liu, Chang Wang, Kun Wang, Li Liu, Qi Shen, Keqiang Yan, Xiaoqing Sun, Jie Chen, Jikai Liu, Hongbo Ren, Hainan Liu, Zhonghua Xu, Sanyuan Hu, Dawei Xu, and Yidong Fan, “SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen Receptor Transcription,” Jnci-Journal of The National Cancer Institute, vol. 105, no. 22, pp. 1719–1728, 2013. View at Publisher · View at Google Scholar
  • Ricarda Locher, Paola A. Erba, Burkhard Hirsch, Emilio Bombardieri, Leonardo Giovannoni, Dario Neri, Horst Dürkop, and Hans D. Menssen, “Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of 131I-L19SIP in a prostate cancer patient,” Journal of Cancer Research and Clinical Oncology, 2013. View at Publisher · View at Google Scholar
  • Matthew R. Cooperberg, Jeffry P. Simko, Janet E. Cowan, Julia E. Reid, Azita Djalilvand, Satish Bhatnagar, Alexander Gutin, Jerry S. Lanchbury, Gregory P. Swanson, Steven Stone, and Peter R. Carroll, “Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort,” Journal Of Clinical Oncology, vol. 31, no. 11, pp. 1428–1434, 2013. View at Publisher · View at Google Scholar
  • Debasish Sundi, Ashley E. Ross, Elizabeth B. Humphreys, Misop Han, Alan W. Partin, H. Ballentine Carter, and Edward M. Schaeffer, “African American Men With Very Low-Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?,” Journal of Clinical Oncology, vol. 31, no. 24, pp. 2991–2997, 2013. View at Publisher · View at Google Scholar
  • Daniel A Barocas, Vivien Chen, Matthew Cooperberg, Michael Goodman, John J Graff, Sheldon Greenfield, Ann Hamilton, Karen Hoffman, Sherrie Kaplan, Tatsuki Koyama, Alicia Morgans, Lisa E Paddock, Sharon Phillips, Matthew J Resnick, Antoinette Stroup, Xiao Cheng Wu, and David F Penson, “Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study,” Journal of Comparative Effectiveness Research, vol. 2, no. 4, pp. 445–460, 2013. View at Publisher · View at Google Scholar
  • Huai-Ching Tai, Ming-Kuen Lai, Chao-Yuan Huang, Shuo-Meng Wang, Kuo-How Huang, Chung-Hsin Chen, Shiu-Dong Chung, Shih-Chieh Jeff Chueh, Hong-Jeng Yu, and Yeong-Shiau Pu, “Laparoscopic Radical Prostatectomy Monotherapy, a More Aggressive Yet Less Invasive Option, Is Oncologically Effective in Selected Men with High-Risk Prostate Cancer Having Only One D'Amico Risk Factor: Experience from an Asian Tertiary Referral Center,” Journal of Endourology, pp. 131017062937009, 2013. View at Publisher · View at Google Scholar
  • Zi-lian Cui, Guan-bin Li, Yu-zhu Xiang, Qing-hua Xia, Xun-bo Jin, Shao-bo Jiang, Yong Zhao, and Hui Xiong, “The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence,” Journal Of Experimental & Clinical Cancer Research, vol. 32, 2013. View at Publisher · View at Google Scholar
  • Elizabeth Handorf, Nicole Crumpler, Laura Gross, and Veda N. Giri, “Prevalence of the HOXB13 G84E Mutation Among Unaffected Men with a Family History of Prostate Cancer,” Journal of Genetic Counseling, 2013. View at Publisher · View at Google Scholar
  • Changsheng Xing, Xiaoying Fu, Xiaodong Sun, and Jin-Tang Dong, “Lack of an Additive Effect between the Deletions of Klf5 and Nkx3-1 in Mouse Prostatic Tumorigenesis,” Journal of Genetics and Genomics, 2013. View at Publisher · View at Google Scholar
  • Jennifer L. Quon, James B. Yu, Pamela R. Soulos, and Cary P. Gross, “The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer,” Journal of Geriatric Oncology, vol. 4, no. 1, pp. 9–18, 2013. View at Publisher · View at Google Scholar
  • Joo Yong Lee, Richilda Red Diaz, Kang Su Cho, and Young Deuk Choi, “Meta-analysis of Transperitoneal Versus Extraperitoneal Robot-Assisted Radical Prostatectomy for Prostate Cancer,” Journal of Laparoendoscopic & Advanced Surgical Techniques, pp. 131001073810004, 2013. View at Publisher · View at Google Scholar
  • Puranik Purushottamachar, Abhijit M. Godbole, Lalji K. Gediya, Marlena S. Martin, Tadas S. Vasaitis, Andrew K. Kwegyir-Afful, Senthilmurugan Ramalingam, Zeynep Ates-Alagoz, and Vincent C. O. Njar, “Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer,” Journal of Medicinal Chemistry, pp. 130607162246006, 2013. View at Publisher · View at Google Scholar
  • Zhi Liu, Yinfu Xu, Ben Sang, Jianbing Mo, Rutong Yu, Xiuping Zhou, Jinming Qian, Lei Hua, and Qiong Shi, “Geranylgeranyltransferase I Promotes Human Glioma Cell Growth through Rac1 Membrane Association and Activation,” Journal Of Molecular Neuroscience, vol. 49, no. 1, pp. 130–139, 2013. View at Publisher · View at Google Scholar